National Workshop on Rare Disease Centres of Reference

Slides:



Advertisements
Similar presentations
Introduction Parkinsons disease is not just a burden for the patients it also has a substantial social and economic impact. The European countries differ.
Advertisements

4 th Meeting of the EC International Dialogue on Bioethics Copenhagen, June 19 th, 2012 Large research and medical databases in clinical and research multi-centred.
Capacity Building for Public Health and Health Promotion in Central and Eastern Europe Caroline Costongs Programme Manager EuroHealthNet
¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
Standard 6: Clinical Handover
Eurordis.org EURORDIS – hvad går det ud på? v. Birthe Byskov Holm, formand Sjældne Diagnoser 1.
Rare Diseases Working Group Luzern, 24 September 2010.
Research & Innovation International Rare Disease Consortium: Data Sharing Policy 3 rd International Traumatic Brain Injury Research Meeting Catherine BERENS.
Fostering entrepreneurial mindsets through education and learning
Information network on rare cancers RARECARENet Annalisa Trama, Gemma Gatta Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)
Trafficking Survivor Care Standards. Care standards working group  In 2013/2014 the Human Trafficking Foundation formed a working group of experts which.
The London Older People Service Development Program (LOPSDP) The ‘Medicines Management’ Project (January to July 2003) Lelly Oboh Project Co-ordinator.
1 EUROPA DONNA – The European Breast Cancer Coalition Susan Knox, Executive Director KEEPING BREAST CANCER ON THE EUROPEAN HEALTH AGENDA.
1 Science and Society: EU Strategy and actions Dr. Rainer GEROLD Director Science and Society Research DG European Commission.
Multnomah County Health Department ►Essential Services ►FDA Food Standards ►PACE Tools for Food Program Excellence Lila Wickham March 17, 2004 ♣
Criteria for Centres of Expertise for Rare Diseases in the EU following EUCERD Recommendations RARECARENet Project: Consensus meeting on.
Objectives of Work Package 5 objectives for today Information on centres of expertise for rare cancers WP leader: Sabine Siesling.
Organ donation Peter Bishop Clinical lead for organ donation.
Handicap-International Challenges of the Sustainability of physical rehabilitation sector Nepal, January 2013.
Washington D.C., USA, July 2012www.aids2012.org The HIV/AIDS Civil Society Forum and Think Tank: from policy to action Anna Zakowicz HIV/AIDS Civil.
Developing trust: Towards Mutual Recognition agreements MERCOSUR – RIACES María José Lemaitre Chile.
National Support Team: Findings from the first 2 years Katrina Stephens Associate Delivery Manager, Alcohol Harm Reduction National Support Team, Department.
National MEDICAL HOME Autism Initiative Poster Presentation for DEC Conference 2005 Linda Tuchman Ginsberg, PhD
C ross-European data sharing made easy EDAF Luxembourg.
A major step towards a Europe for Health Directive on patients’ rights in cross-border healthcare DG SANCO D2 Healthcare Systems.
Dr. David Mowat June 22, 2005 Federal, Provincial & Local Roles Surveillance of Risk Factors and Determinants of Chronic Diseases.
PRISON HEALTH IN EUROPE: MISSIONS, ROLES AND RESPONSIBILITIES OF INTERNATIONAL ORGANIZATIONS Strasbourg, France 27 th May 2014.
Health Promotion as a Quality issue
Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
Volservnet Voluntary Services and Networking A project in collaboration with the Ministry of Health, the Elderly and Community Care.
The partnership principle and the European Code of Conduct on Partnership.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
PHE Local Intelligence Contribution David Meechan, Director for Knowledge & Intelligence (East Midlands), Public Health England.
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
1 A Multi Level Approach to Implementation of the National CLAS Standards: Theme 1 Governance, Leadership & Workforce P. Qasimah Boston, Dr.Ph Florida.
TAIEX Workshop on the Implementation of EU Pharmacovigilance Legislation - BELGRADE CLAUDIA PANAIT TAIEX Expert – European Commission Legal Adviser.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
Increased # of AI/AN receiving in- home environmental assessment and trigger reduction education and asthma self-management education Increased # of tribal.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
European Agency for Development in Special Needs Education Project updates Marcella Turner-Cmuchal.
European Patients’ Academy on Therapeutic Innovation – The project is receiving support from the.
Working effectively as a team.
A capacity building programme for patient representatives
Interprofessional Health care Teams
Ahousaht Comprehensive Community Planning Leader, Guy Louie
Health Promotion & Aging
Call for Action & International Initiative
TRAINING POLICY FOR AVIATION SAFETY IN AFRICA
Musculoskeletal Health in Europe
HEALTH IN POLICIES TRAINING
C-SCOPE: Survey on the Management of HCV in addiction clinics treating Patients on Opiate Agonist Therapies: a global perspective July 2017.
Helen Lee, European Commission
Helpful Hints for action to prevent elder abuse
Strategies to increase family engagement
HPH Strategy Seminar Beijing, China 7 september 2013 Andrea Limbourg
Introduction to the training
The role of the ECCP (1) The involvement of all relevant stakeholders – public authorities, economic and social partners and civil society bodies – at.
Blueprint Outlines practical, consumer-focused, state and local strategies for improving eating and physical activity that will lead to healthier lives.
SOCIAL DIALOGUE WITHIN EUPAN
ESS Vision 2020.
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Essential Drugs and Medicines Policy
Regional Oncology Social Work
Essential Drugs and Medicines Policy
ESS Vision 2020.
Presentation transcript:

National Workshop on Rare Disease Centres of Reference Objectives of the Rapsody Project Rare Disease Patient Solidarity EC 2005120 Update on the Rapsody project Birthe Byskov Holm Rare Disorders Denmark Eurordis Budapest Parliament March 19th. 2008

The Rapsody Workshops Objectives To engage and to develop dialogue between patients, health care professionals, health care systems experts and health authorities To address needs and expectations primarily of patients and families but also health professionals and policymakers regarding National centres of expertise for rare diseases European reference networks of centres of expertise

The Rapsody workshops objectives To develop recommendations for Principles and criteria for the identification of national centres of expertise and European reference networks The evaluation of their respective outcomes

The Rapsody workshops Dialogue on National Centres of Expertise and European Reference Networks was facilitated both on National and European level From March to July 2007 11 one day meetings in 11 member states The same agenda, the same format and the same composition of audience Over all, 274 participants: 133 patients representatives, 106 health care professionals, 35 policy makers In July 2007 A two-days European workshop in Prague Organized together with the Czech Republic Drug Agency 80 participants (patient, professionals, policy makers) from 13 countries

The Rapsody workshops Dialogue on National Centres of Expertise and European Reference Networks was facilitated both on National and European level In November 2007 in Lisbon European Conference on Rare Diseases 426 participants from 35 countries of which 25 from EU/EEA Commission Communication on Rare Diseases expected by the end of 2008.

The Rapsody Workshops

The Rapsody Project Acknowledgement The Advisory Committee Patient representatives Simona Bellagambi - Italy, Tuberous sclerosis Organisation and UNIAMO Christel Nourissier - France, Prader Willi and Alliance Nationale Maladies Rares Rosa Sanchez de Vega - Spain, Aniridia and Federacion Española de Enfermedades Raras FEDER Health care professionals Prof. Dian Donnaï - UK, Medical Genetics, St Mary's Hospital Prof Birgitta Strandvik - Sweden, Inst.of the Health of Women and Children, Göteborg University Prof Olaf Rieß - Germany, University of Tübingen / Department of Medical Genetics Health policy makers Dr Alexandra Fourcade - France, Ministry of Health & EU High Level Group on Health Services and Medical Care Dr Ségolène Aymé - France, Orphanet and DG SANCO Rare Diseases Task Force Dr Edmund Jessop - UK, Department of Health, National Specialist Commissioning Advisory Group (NSCAG) & DG SANCO Rare Diseases Task Force

The Rapsody Project Acknowledgements Project Leader Yann Le Cam, CEO Eurordis Project Manager Framcois Houyes, Health Policy Officer Eurordis Flaminia Macchia Bangsgaard, European Public Affairs, Eurordis

The Rapsody Workshops Objectives The participants of the national workshops were asked the following questions: Needs and expectations for national rare disease centres of expertise Proposals for the evaluation of national centres of reference in your country Cooperation with other countries and recommendations for European reference networks

The Rapsody workshops agenda Cooperation with other countries and recommendations for European reference networks How do you see your centres cooperating at the EU level? What role would European reference networks play? Which specific added value can you identify when networking your national centres of expertise at European level? On which criteria to identify/designate European reference networks? And what would the expected specific benefits for patients be?

The Rapsody workshops outcomes In summary Main criteria for the designation of centres of expertise Two essential pre-conditions: Professional qualifications with both clinical and scientific experience. Proven qualifications documented by publications, grants, pre-existing certification or accreditation Commitment to cooperate and to share information Importance of the general ” atmosphere and attitude” : trust rather than competition among experts to ensure effective cooperation.

The Rapsody Workshops Outcome In summary Main criteria for the designation of centres of expertise: Patient acces to a multidisciplinary team of experts Combine research and care Importance of coordination between professionals Importance of a global approach(holistic and comprehensive)integrating medical and social aspects Participation in research activities at European and International level

The Rapsody Workshops Outcomes In summary Main criteria for the designation of centres of expertise Perform education, information and communication outreach activities with the public and primary health care professionals Perform training activities for health professionals Perform activities to empower patients and collaborate with patients organisations.

The Rapsody Workshops Outcomes In summary Additional criteria for the funding of European reference networks Capacity to provide expert advice, diagnosis or confirmation of diagnosis, to produce and adhere to good practice guidelines and to implement outcome measures and quality control Involvement in epidemiological surveillance, such as registries

The Rapsody WorkShops Outcomes In summary Additional criteria for the funding of European reference networks Close links and collaboration with other expert centres at national and international level and capacity to network Appropriate arrangements for referrals of patients from other Member States within a framework

The Rapsody Workshops Outcomes In summary Methods for evaluation European reference networks should be: Initially evaluated and accredited af EU level via a set of criteria( minimum set of standardised criteria and objectives Regularly assesed on common indicators with soft and hard values.

The Rapsody workshops outcomes Patients access to a multidisciplinary team of experts: Both at the level of centres of expertise and European networks Full competence does not exist in any single member state Cross-disciplinary approach is needed to meet rare disease patients needs

The Rapsody workshops outcomes Importance of coordination between professionals: Coordination within and between centres of expertise, within European networks, between centres of expertise and primary care Coordination between care and research activities An intelligent way of circulating information and organising the continuum of activities by placing the patient at the centre and making better use of existing expertise and resources In order to improve quality of care and to reduce the psychological burden of the patient ( feeling lost in the system, lack of support, language barriers)

The Rapsody Workshops Outcomes Importance of a global approach( holistic, comprehensive) integrating medical and social aspects At all levels (primary care centres, centres of expertise, European networks Social support often underestimated Need to develop a common European approach to social services for rare diseases Specific administrative tasks for European networks to support patient mobility for cross-border care, addressing the reimbursement issue.

The Rapsody Workshops Outcomes Capacity to pool patients The critical mass of patients is a condition for increasing scientific and medical knowledge on the disease. The identification of unknown aetiologies will help the management of complex and rare situations, but on the condition that enough patients can be enrolled in trials.

The Rapsody Workshops Outcomes General expectations: Development of best practices, standards and guidelines for diagnosis, treatment and care of rare diseases at international level Dissemination of European reference diagnostic and therapeutic protocols will ensure equity at EU level by reducing the impact of the ” post code lottery ” and will increase trust in local services Provision of expert opinion, confirmation of diagnostic and therapeutic options.

The Rapsody Workshops Outcomes Research activities at European and International level: Linking excellence of care with excellence of research, where the patients are and where the multidisciplinary expertise on the disease is Multi-centre clinical studies and facilitation of partnership with pharmaceutical companies Shared databases, shared biological resources (DNA,RNA, tissues, cells) registries (harmonisation of procedures), international epidemiological surveillance, pharmacovigilance. Participation in EU-funded research projects

The Rapsody Workshops Outcomes Perform education and training Information and communication outreach activities with the public and the primary health care professionals( to improve referrals and follow up) Training activities for health professionals, including staff exchanges, meetings and conferences to exchange best practices, to harmonise processes and to disseminate standards and guidelines

The Rapsody Workshops Outcomes Activities to empower patients. At different levels Information, education, training To build patients and families capacity to manage the medical and social aspects of their rare disease, to enhance their autonomy, increase their compliance and help improve their quality of life.

The Rapsody Workshops Outcomes Collaborate with patient organisations at different levels: Patient organisations contribution to the management and evaluation of networks Facilitate the creation of patient groups Improve links and exchanges between professionals( care and research) and patients More broad links between European reference networks, research networks and patient organisations

The Rapsody Workshops Outcomes A general agreement is that European reference networks should be: Initially evaluated and accredited at EU level via an agreed set of criteria (minimum set of standardised criteria and objectives) Regularly assessed on common indicators with soft values and hard values There is a need to develop methods and tools for European reference networks to perform regular self-evaluation.

The Rapsody Workshops Outcomes Soft values Cooperation with patient org. Patient oriented approach Improved outcomes Improved atmosphere Improved quality of life Avoiding unnecessary complications Awareness and knowledge dissemination Information provision to local centres Hard values time to diagnose Waiting time Genetic consultation Multidisciplinary approach Cooperation with other centres Guidelines / recommendations Quality control International /national networking Economic assessment

The Rapsody Workshops Outcomes Economic and management aspects of European reference networks Reference networks are perceived to be cost-effective They need proper funding for their specific European and international activities They need long term sustainable public funding They should be encouraged to share good governance practice, organisation, leadership, regulation, steering committee) and coordination practice between them. They should be able to disclose their procedures and their outcomes

The Rapsody Workshops Outcomes Importance of flexibility when selecting types of centres belonging to the networks and flexibility in relation to the geographic coverage of the networks No obligation for a network to have centres in all member states. Density of centres depends on population size. European networks could play an active role in the accreditation of national centres of expertise Patients agreement to travel should be confirmed, detailed and responded to.

The Rapsody Workshops Outcomes Different suggestions were made on the structure of the networks, with ” leading centres” and ” associated centres” and possible” sub-national networks” with ” centres of competence”. Different type of centres and with different related diseases could be grouped within a European network Excellent contribution of new member states to European reference networks

The Rapsody Project